| pubmed-article:6963330 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6963330 | lifeskim:mentions | umls-concept:C0007226 | lld:lifeskim |
| pubmed-article:6963330 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:6963330 | lifeskim:mentions | umls-concept:C2003941 | lld:lifeskim |
| pubmed-article:6963330 | pubmed:issue | 5-6 | lld:pubmed |
| pubmed-article:6963330 | pubmed:dateCreated | 1983-6-17 | lld:pubmed |
| pubmed-article:6963330 | pubmed:abstractText | The effects of 15(S) 15-methyl-PGF2 alpha were studied on the cardiovascular system of dogs. Intravenous and intravertebral artery administration of 15(S)-methyl-PGF 2 alpha induced arterial hypertensive and respiratory effects more intense and longer lasting than those observed for PGF2 alpha. Intravenous administration of 15(S) 15-methyl-PGF2 alpha induced a decrease of vascular reactivity to 1-norepinephrine and 1-epinephrine and to carotidal occlusion. Infiltration of the carotid sinus walls with 15(S) 15-methyl-PGF2 alpha decreased the baroreceptor reactivity. | lld:pubmed |
| pubmed-article:6963330 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6963330 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6963330 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6963330 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6963330 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6963330 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6963330 | pubmed:issn | 0025-7850 | lld:pubmed |
| pubmed-article:6963330 | pubmed:author | pubmed-author:MarmoEE | lld:pubmed |
| pubmed-article:6963330 | pubmed:author | pubmed-author:VaccaCC | lld:pubmed |
| pubmed-article:6963330 | pubmed:author | pubmed-author:SpadaroRR | lld:pubmed |
| pubmed-article:6963330 | pubmed:author | pubmed-author:BilzRR | lld:pubmed |
| pubmed-article:6963330 | pubmed:author | pubmed-author:FilippelliAA | lld:pubmed |
| pubmed-article:6963330 | pubmed:author | pubmed-author:FilippelliWW | lld:pubmed |
| pubmed-article:6963330 | pubmed:author | pubmed-author:CalopriceAA | lld:pubmed |
| pubmed-article:6963330 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6963330 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:6963330 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6963330 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6963330 | pubmed:pagination | 387-98 | lld:pubmed |
| pubmed-article:6963330 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:6963330 | pubmed:meshHeading | pubmed-meshheading:6963330-... | lld:pubmed |
| pubmed-article:6963330 | pubmed:meshHeading | pubmed-meshheading:6963330-... | lld:pubmed |
| pubmed-article:6963330 | pubmed:meshHeading | pubmed-meshheading:6963330-... | lld:pubmed |
| pubmed-article:6963330 | pubmed:meshHeading | pubmed-meshheading:6963330-... | lld:pubmed |
| pubmed-article:6963330 | pubmed:meshHeading | pubmed-meshheading:6963330-... | lld:pubmed |
| pubmed-article:6963330 | pubmed:meshHeading | pubmed-meshheading:6963330-... | lld:pubmed |
| pubmed-article:6963330 | pubmed:meshHeading | pubmed-meshheading:6963330-... | lld:pubmed |
| pubmed-article:6963330 | pubmed:meshHeading | pubmed-meshheading:6963330-... | lld:pubmed |
| pubmed-article:6963330 | pubmed:meshHeading | pubmed-meshheading:6963330-... | lld:pubmed |
| pubmed-article:6963330 | pubmed:meshHeading | pubmed-meshheading:6963330-... | lld:pubmed |
| pubmed-article:6963330 | pubmed:meshHeading | pubmed-meshheading:6963330-... | lld:pubmed |
| pubmed-article:6963330 | pubmed:meshHeading | pubmed-meshheading:6963330-... | lld:pubmed |
| pubmed-article:6963330 | pubmed:meshHeading | pubmed-meshheading:6963330-... | lld:pubmed |
| pubmed-article:6963330 | pubmed:meshHeading | pubmed-meshheading:6963330-... | lld:pubmed |
| pubmed-article:6963330 | pubmed:meshHeading | pubmed-meshheading:6963330-... | lld:pubmed |
| pubmed-article:6963330 | pubmed:year | 1982 | lld:pubmed |
| pubmed-article:6963330 | pubmed:articleTitle | Cardiovascular effects of 15(S) 15 methyl-PGF2 alpha. | lld:pubmed |
| pubmed-article:6963330 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6963330 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
